You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • S35 Efficacy and safety of the direct switch from various previous treatments to glycopyrronium or indacaterol/glycopyrronium in patients with moderate copd: the crystal study

Citation Tools

Article menu
Download PDFPDF
Beyond FEV1 in COPD
S35 Efficacy and safety of the direct switch from various previous treatments to glycopyrronium or indacaterol/glycopyrronium in patients with moderate copd: the crystal study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Vogelmeier C, Aalamian-Mattheis M, Greulich T, et al
S35 Efficacy and safety of the direct switch from various previous treatments to glycopyrronium or indacaterol/glycopyrronium in patients with moderate copd: the crystal study
Thorax 2016;71:A22.